Cognitive Preliminary Evidence
DSIP
Delta Sleep-Inducing Peptide
1 min read
Regulatory Status
🇺🇸 United States
Grey Area Included in the broader FDA review set with unresolved safety and efficacy questions.
FDA · Updated Apr 2026
🇬🇧 United Kingdom
Research Use Only Primarily framed as research-only.
MHRA · Updated Apr 2026
🇦🇺 Australia
Grey Area Market treatment remains inconsistent.
TGA · Updated Apr 2026
🏅 WADA
Not Assessed Not specifically listed in the current WADA notes used here.
WADA · Updated Apr 2026
Overview
DSIP is a sleep-associated peptide with a small and uneven evidence base. It remains more notable for recurring commercial claims than for strong contemporary human data.
Continue Reading